The impact of eltrombopag administration on the clinical course of severe refractory fatal acquired aplastic anemia
Turk J Haematol
.
2013 Sep;30(3):328-30.
doi: 10.4274/Tjh-2013.0005.
Epub 2013 Sep 5.
Authors
Ayşe Işık
1
,
Eylem Eliaçık
1
,
Ibrahim C Haznedaroğlu
1
,
Salih Aksu
1
,
Nilgün Sayınalp
1
,
Yahya Büyükaşık
1
,
Hakan Göker
1
,
Osman Ozcebe
1
Affiliation
1
Hacettepe University Faculty of Medicine, Division of Hematology, Ankara, Turkey.
PMID:
24385816
PMCID:
PMC3878545
DOI:
10.4274/Tjh-2013.0005
No abstract available